Eckert, Kathryn M.
Hoskin, Tanya L.
Olson, Carrie A.
Goetz, Matthew P.
Boughey, Judy C. http://orcid.org/0000-0003-3820-3228
Funding for this research was provided by:
Mayo Clinic Breast Cancer Specialized Program of Research Excellence Grant (P50CA 116201)
Article History
Received: 10 July 2024
Accepted: 27 August 2024
First Online: 12 September 2024
Disclosures
: Dr. Judy Boughey receives funding paid to her institution from Eli Lilly and SymBioSis and sits on the Data Safety Monitoring Committee of CairnsSurgical. She has received honoraria from PER, PeerView, OncLive, EndoMag, and Up-To-Date. Dr. Matthew Goetz is the Erivan K. Haub Family Professor of Cancer Research Honoring Richard F. Emslander, M.D. and reports personal fees for CME activities from IDEOlogy Health, Research to Practice, Medscape, and MJH Life Sciences; personal fees for serving as a panelist for a panel discussion from Total Health Conferencing and personal fees for serving as a moderator for Curio Science; consulting fees to Mayo Clinic from ARC Therapeutics, AstraZeneca, Biotheranostics, Blueprint Medicines, eChinaHealth, EcoR1, Lilly, Novartis, RNA Diagnostics, Sanofi Genzyme, Seattle Genetics, Sermonix, Engage Health Media, Laekna, and TerSera Therapeutics/Ampity Health; grant funding to Mayo Clinic from Lilly, Pfizer, Sermonix, Loxo, AstraZeneca, and ATOSSA Therapeutics; and travel support from Lilly.